Resources
Fraud & Abuse Laws/Regulations
Eliminating Kickbacks in Recovery Act (18 USC §220) ›
Federal Anti-Kickback Statute (42 USC §1320a-7b) ›
Federal Civil False Claims Act (31 USC §3729 et seq.) ›
Federal Civil Monetary Penalties Statute (42 USC 1320a-7a) ›
Federal Exclusion Law (42 USC §1320a–7) ›
Federal Health Care Fraud Law (18 USC §1347) ›
Federal Stark Law (42 USC §1395nn) ›
Industry Codes of Conduct
Federal Sentencing Guidelines ›
OIG Compliance Program Guidance For Pharmaceutical Manufacturers ›
OIG Compliance Program Guidance for Clinical Laboratories ›
ACCME Standards for Commercial Support ›
AdvaMed Code of Ethics On Interactions with U.S. Health Care Professionals ›
American Medical Association (AMA) Code of Medical Ethics ›
American Society of Clinical Laboratory Science (ASCLS) Code of Ethics ›
Biotechnology Innovation Organization (BIO) Policies ›
Corporate Health Care Compliance Resources
Office of Inspector General (OIG) Advisory Opinions ›
OIG Corporate Integrity Agreements (CIA) ›
OIG Self-Disclosure Guidance ›
OIG Special Fraud Alerts, Bulletins and Other Guidance ›
Regulatory Compliance
Centers for Medicare & Medicaid Services (CMS) Regulations & Guidance ›
Food & Drug Administration (FDA) Guidance ›
FDA Office of Prescription Drug Promotion (OPDP) ›
Drug/Device/Biologics/GPO Transparency & Price Reporting Laws
Federal Physician Payments Sunshine Act Transparency Law
Centers for Medicare & Medicaid Services (CMS) Open Payments ›
State & Local Marketing, Licensure & Transparency Laws
Chicago ›
DC Pharmaceuticals Detailers License Law ›
Maine ›
Nevada ›
Vermont ›
State Price Reporting Laws
Maine ›
Nevada ›
Oregon ›
Texas ›
Vermont ›
HIPAA/Privacy/Cybersecurity
Office of Civil Rights (OCR) HIPAA/Health Information Privacy ›
Federal Trade Commission (FTC) Health Breach Notification Rule ›
AMA HIPAA Breach Notification Rules resources ›